Nyxoah SA
NYXH4.730USD
+0.080+1.72%
收盘 02/09, 16:00（美东）报价延迟15分钟
101.33M总市值
亏损市盈率 TTM
关于 Nyxoah SA 公司
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Nyxoah SA简介
公司代码NYXH
公司名称Nyxoah SA
上市日期Sep 18, 2020
CEOTaelman (Olivier)
员工数量- -
证券类型Ordinary Share
年结日Sep 18
公司地址Rue Edouard Belin 12
城市MONT-SAINT-GUIBERT
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Belgium
邮编1435
电话3226121755
网址https://www.nyxoah.com/
公司代码NYXH
上市日期Sep 18, 2020
CEOTaelman (Olivier)
Nyxoah SA公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
4.31M
+70000.00%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Francis Kim
Mr. Francis Kim
Chief Regulatory and Quality Officer
Chief Regulatory and Quality Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
4.31M
+70000.00%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 1月18日 周日
更新时间: 1月18日 周日
持股股东
股东类型
持股股东
持股股东
占比
Cochlear Limited
13.59%
Taub (Robert)
10.02%
Monden (Anneliese)
6.83%
Gilde Healthcare Partners B.V.
6.83%
ResMed Inc
4.02%
其他
58.72%
持股股东
持股股东
占比
Cochlear Limited
13.59%
Taub (Robert)
10.02%
Monden (Anneliese)
6.83%
Gilde Healthcare Partners B.V.
6.83%
ResMed Inc
4.02%
其他
58.72%
股东类型
持股股东
占比
Individual Investor
19.98%
Corporation
17.61%
Investment Advisor
8.68%
Venture Capital
7.02%
Investment Advisor/Hedge Fund
5.74%
Hedge Fund
0.63%
Research Firm
0.17%
其他
40.19%
机构持股
更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
80
9.57M
22.23%
+53.45K
2025Q3
74
8.21M
21.94%
-2.04M
2025Q2
69
25.16M
67.22%
-3.01M
2025Q1
70
26.40M
70.53%
-2.65M
2024Q4
73
25.60M
68.47%
-1.01M
2024Q3
72
23.51M
71.46%
-828.78K
2024Q2
72
23.54M
72.39%
-1.11M
2024Q1
64
20.89M
72.68%
+374.51K
2023Q4
59
21.08M
73.36%
-418.05K
2023Q3
66
19.86M
69.10%
-2.56M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Cochlear Limited
5.85M
13.59%
+215.96K
+3.84%
Nov 20, 2025
Taub (Robert)
4.31M
10.02%
+70.00K
+1.65%
Dec 01, 2025
Monden (Anneliese)
2.94M
6.83%
--
--
Dec 31, 2024
Gilde Healthcare Partners B.V.
2.94M
6.83%
--
--
Dec 31, 2024
ResMed Inc
1.73M
4.02%
--
--
Dec 31, 2024
BNP Paribas Asset Management Belgium S.A.
732.78K
1.7%
--
--
Nov 30, 2025
Hambrecht (Jürgen)
1.34M
3.12%
--
--
Dec 31, 2024
Vestal Point Capital, LP
1.11M
2.57%
-294.59K
-21.01%
Sep 30, 2025
Heights Capital Management, Inc.
831.43K
1.93%
+831.43K
--
Dec 18, 2025
BlackRock Financial Management, Inc.
647.21K
1.5%
-36.44K
-5.33%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
iShares Health Innovation Active ETF
0.09%
Avantis International Equity ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SPDR Portfolio Europe ETF
0%
DFA Dimensional International Small Cap ETF
0%
Avantis International Small Cap Equity ETF
0%
iShares Health Innovation Active ETF
占比0.09%
Avantis International Equity ETF
占比0%
DFA Dimensional International Core Equity 2 ETF
占比0%
SPDR Portfolio Europe ETF
占比0%
DFA Dimensional International Small Cap ETF
占比0%
Avantis International Small Cap Equity ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
